BCRX

#1723
BioCryst Pharmaceuticals Inc
8.75
+13.49%
Sector:
Base:
Profit Currency:
Daily Range
8.75
8.75
Year Range
6.00
11.31
Daily Change
+13.49%
Monthly Change
+29.44%
6 month change
+2.70%
Year Change
+2.82%
Previous Close
7.71
Open
8.75
Bid
Ask
Low
8.75
High
8.75
Volume
173
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025

BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

News